MAP1LC3A and esophageal cancer: The number of LC3 fluorescence in the combination of the SJC and chloroquine treatment group was higher than that of the combination of SJC treatment group, indicating that the combination of drugs partially inhibited the degradation of autophagosomes, and further documenting that SJC promotes autophagy in esophageal cancer KYSE-150 cells.